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Abstract
The closely related members of the Acinetobacter baumannii (Ab) group (A. baumannii, A. pittii and A. nosocomialis) are difﬁcult to identify
with phenotypic tests in diagnostic laboratories. Genotypic identiﬁcation methods require special skills and most do not provide rapid
results. The aim of this study was to investigate the ability of MALDI-TOF MS to identify members of the Ab group. Sixty epidemiologi-
cally unrelated Acinetobacter spp. isolates were investigated by MALDI-TOF MS: 18 A. baumannii, 17 A. pittii, 18 A. nosocomialis and seven
additional isolates representing other Acinetobacter spp. All strains were veriﬁed by ARDRA, rRNA intergenic spacer (ITS), recA
sequencing and blaOXA-51. MALDI-TOF MS correctly identiﬁed all the genomic strains but erroneously identiﬁed A. nosocomialis as
A. baumannii because there was no reference strain within the Bruker database. Peak analysis of individual spectra from representative
strains of each member of A. baumannii, A. pittii and A. nosocomialis suggested enough differences between their protein signatures to
allow accurate identiﬁcation using MALDI-TOF MS. Inclusion of speciﬁc signature proﬁles for A. nosocomialis within the Bruker database
allowed the correct identiﬁcation of this genomic species. MALDI-TOF MS spectra can be used as a fast, simple and reliable method to
identify members of the Ab group. The rapid and accurate identiﬁcation of clinically signiﬁcant Acinetobacter strains will improve insight
into their epidemiology and allow for targeted therapeutic and infection control measures against clinically important strains.
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Introduction
The Acinetobacter genus comprises Gram-negative non-fer-
menting coccobacilli with 25 validly named species and nine
genomic species deﬁned by genomic DNA-DNA hybridiza-
tion [1]. Among these, Acinetobacter baumannii constitutes
the most important species causing nosocomial infections,
particularly in intensive care units (ICU) [2], although A. pittii
and A. nosocomialis (formerly Acinetobacter genomic species 3
and gen. sp. 13TU, respectively [3]) are emerging as impor-
tant pathogens and have been involved in a number of out-
breaks in ICUs [1]. A. baumannii, A. pittii and A. nosocomialis
as well as the environmental species A. calcoaceticus are
highly similar from a phenotypic point of view as well as by
DNA-DNA hybridization, which has led to their inclusion in
the A. calcoaceticus-A. baumannii (Acb) complex [4]. In fact,
the three clinically important members of this group, also
known as the A. baumannii (Ab) group [2], are so much alike
that they cannot be differentiated by currently available iden-
tiﬁcation systems and A. pittii and A. nosocomialis are often
erroneously identiﬁed as A. baumannii by routine commercial
systems such as API and VITEK (bioMe´rieux, Marcy l’Etoile,
France) or PHOENIX (Becton Dickinson, Franklin Lakes, NJ,
USA.) [5,6].
Genotypic methodologies to distinguish individual genomic
species have been developed, including ampliﬁed 16S ribo-
somal DNA restriction analysis (ARDRA) [7], tRNA spacer
ﬁngerprinting [8] and selective ampliﬁcation of restriction
fragments (AFLP) [9]. Speciﬁc gene sequences can also be
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used, including the intergenic spacer (ITS) region between
the 16S–23S rRNA genes [10], recA [11], rpoB [12] and gyrB
[13], although not all of these methods successfully discrimi-
nate among members of the Ab group. In addition, most of
these methodologies are laborious, time-consuming, require
special skills and are unsuitable for use in routine clinical
identiﬁcation. Failure to correctly identify clinical isolates
below the Ab group level may be misleading because infec-
tions caused by the different species within this group may
differ in their clinical outcome [14]. Organisms belonging to
these three species display different characteristics regarding
colonization of human skin, antimicrobial susceptibility and
mortality rates [14,15]. Therefore, a more rapid and accu-
rate identiﬁcation strategy is needed.
Matrix-assisted laser desorption ionization-time of ﬂight
(MALDI-TOF) mass spectrometry (MS) has been adapted for
the identiﬁcation of different microorganisms at the genus,
species or subspecies level and has proven to be a very
user-friendly technique requiring tiny amounts of sample yet
providing accurate results within minutes. MALDI-TOF MS
generates protein ﬁngerprint signatures that can rapidly be
compared with those in a database of reference spectra [16].
Although MALDI-TOF MS has been applied to the identiﬁca-
tion of non-fermenting bacteria, including some Acinetobacter
species [17–19], it has never been tested with different
members of the Ab group.
The present study was undertaken to evaluate the use of
MALDI-TOF MS in the identiﬁcation of members of the Ab
group and to compare its discriminatory power with that of
ARDRA, recA and ITS sequencing.
Materials and Methods
Bacterial isolates
Sixty epidemiologically unrelated Acinetobacter spp. isolates
were included in the study: a set of known clinical isolates
from our collection, 16 A. pittii, 16 A. nosocomialis and 13
A. baumannii; and a set of reference strains, RUH 204 (A. junii),
RUH 509 (A. pittii), RUH 503 (A. nosocomialis), RUH 44 (A. hae-
molyticus), RUH 45 (A. lwofﬁi), RUH 3517 (A. radioresistens),
RUH 584 (A. calcoaceticus), RUH 875 (A. baumannii, European
clone I), RUH 134 (A. baumannii, European clone II), RUH
5875 (A. baumannii, European clone III), 17BJ-209 (Acinetobac-
ter gen. sp. 17), A. haemolyticus-JV, A. baumannii AYE strain,
A. baumannii ATCC 19606 and A. nosocomialis ATCC 17903.
Ampliﬁcation of the ITS region, recA and blaOXA-51
Ampliﬁcation of the ITS region, recA and blaOXA-51 was per-
formed according to Chang et al. [10], Nowak et al. [20] and
Ruı´z et al. [21], respectively. Puriﬁed PCR products were
analysed by gel electrophoresis or sent for sequencing and
compared among all sequences and reference strains.
ARDRA
The complete 16S rRNA gene was ampliﬁed as described in
[7]. Aliquots of the PCR product were independently
digested with AluI, CfoI, MboI, MspI and RsaI (Promega Bio-
tech Ibe´rica, Madrid, Spain). Restriction patterns were analy-
sed by gel electrophoresis in 2.5% (w/v) agarose and
patterns were compared with the library proﬁles described
in [7].
MALDI-TOF MS
MALDI-TOF was conducted on a Microﬂex LT (Bruker Dal-
tonics GmbH, Leipzig, Germany) benchtop instrument oper-
ated in linear positive mode under control of the FlexControl
3.0 software (Bruker Daltonics) at a laser frequency of 20 Hz
within a range mass from 2000 to 20000 Da.
Mass spectra were processed using FlexAnalysis 3.0 soft-
ware (Bruker Daltonics). External calibration was performed
using the Bruker Daltonics Bacterial Test standard according
to the manufacturer’s instructions.
Bacterial extracts. Pure cultures were grown on Columbia
sheep blood agar (Becton Dickinson) at 37C for 24 h. One
full 1 lL sterile loop of bacterial sample was suspended in
300 lL of sterile water and mixed with 900 lL of absolute
ethanol. Samples were centrifuged at 12 000 g for 2 min and
the supernatant was discarded. The pellet was resuspended
in 50 lL of 70% formic acid (Sigma chemical Co., St Louis,
MO, USA) and 50 lL of acetonitrile (Sigma) and centrifuged
at 12 000 g for 2 min. The supernatant was collected and
stored at )20C.
Generation of a local database. One microlitre of each bacte-
rial extract from three strains each of A. baumannii (RUH
875, RUH 134, RUH 5875), A. pittii (52, 60, 69) and A. noso-
comialis (95, 192, 212), was spotted eight times onto a
ground steel target and air-dried. Each sample was overlaid
with 1 lL of a saturated matrix solution of a-cyano-4-
hydroxy-cinnamic acid (Bruker Daltonics) in 50% acetonitrile
(Sigma), 2.5% triﬂuoroacetic acid (Sigma) and air-dried. Each
spot was measured three times. Every measurement was the
sum spectrum accumulated from 250 laser shots (5 · 50
laser shots on different locations according to a predeﬁned
lattice raster). The resulting 24 spectra were carefully analy-
sed using the FlexAnalysis software to yield a minimum of 20
accurate spectra that were uploaded onto the MALDI Bio-
Typer 2.0 software (Bruker Daltonics) to create a single
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mean spectrum (MSP) for each strain with the BioTyper MSP
creation standard method.
Identiﬁcation of sample bacterial extracts. MALDI-TOF MS anal-
ysis was performed from bacterial extracts or directly from
grown colonies. Two bacterial extracts from independent
cultures were generated for each tested strain; 1 lL of each
extract was spotted onto a ground steel target and overlaid
with 1 lL of matrix. To perform direct colony analysis a
small fraction of a single colony was spread over two spots
and overlaid with 1 lL of matrix. This procedure was per-
formed twice.
Each sample spot was measured as before and analysed
with the MALDI BioTyper against either the default Bruker
database or the association of the Bruker database and our
own reference spectra. Accuracy of the identiﬁcation was
determined by a logarithmic score value resulting from the
alignment of peaks to the best matching reference spectrum.
According to the manufacturer: a log score >2.3 indicated
highly probable species identiﬁcation; a score value between
2.0 and 2.3 indicated secure genus identiﬁcation and proba-
ble species identiﬁcation; a score value between 1.7 and 2.0
indicated probable genus identiﬁcation; and a score value
<1.7 was considered as a non-reliable identiﬁcation (Table 1).
Optimal identiﬁcation was granted when two independent
spectra were within the same log score range.
Data analysis. The MALDI-TOF MS-generated dendogram
was constructed using the correlation distance measure with
the average linkage algorithm settings of the BioTyper 2.0
software.
Sequence analysis of ITS and recA was performed by simi-
larity searches against nucleotide databases (http://blas-
t.ncbi.nlm.nih.gov/Blast.cgi). Identiﬁcation to the species level
was conﬁrmed when the matching sequence displayed at
least 96% identity within a 99% coverage to the query
sequence. Phylogenetic analysis was performed with MEGA
version 5 [22]. MUSCLE was used for sequence alignment
[23] and phylogenetic trees were constructed using the
neighbour-joining method with genetic distances computed
by Kimura’s two-parameter model [24] with a bootstrap
value of 1000 replicates.
Results and Discussion
Sixty previously characterized Acinetobacter isolates including
18 A. nosocomialis strains, 17 A. pittii strains, 18 A. baumannii
isolates as well as seven reference strains representing vari-
ous other Acinetobacter spp. were analysed by genotypic
methods and MALDI-TOF MS. Bacterial extracts were analy-
sed by MALDI-TOF MS and compared against the default
Bruker database. Accurate identiﬁcation at the species level
was achieved for all reference strains but one, all A. bauman-
nii strains and all but one of the A. pittii isolates. However,
the MALDI BioTyper software erroneously identiﬁed the 18
A. nosocomialis strains as A. baumannii with MALDI scores <2,
which was already expected due to the lack of A. nosocomial-
is-speciﬁc signatures within the Bruker database.
Peak analysis of individual spectra from representative
strains of A. baumannii, A. pittii and A. nosocomialis, however,
suggested enough differences between their protein signa-
tures to allow accurate identiﬁcation using MALDI-TOF MS
(Fig. 1). Hence, three strains each of A. baumannii, A. pittii
and A. nosocomialis were chosen to create a set of reference
spectra to complement the Bruker database.
Cluster analysis showed that the protein signatures from
A. nosocomialis form a separate cluster closely related to that
of A. baumannii (Fig. 2).
Spectra from all 60 isolates were re-analysed against a local
database that incorporated the reference signatures for
A. nosocomialis and this time MALDI-TOF MS analysis pro-
vided unambiguous identiﬁcation for all A. nosocomialis strains.
Overall, 98.3% of all isolates were identiﬁed at the species
level: 86.7% (52/60) showed a log score >2.3; 11.6% (7/60)
were identiﬁed with a log score between 2.0 and 2.3; and
only 1.7% (1/60) were identiﬁed at the probable genus level
with a log score between 1.7 and 2.0. None of the isolates
reported a log score <1.7 (Table 1).
All A. baumannii and A. nosocomialis strains produced log
scores >2.3 while four A. pittii isolates were identiﬁed with
log scores between 2.0 and 2.3. Hence, only 76.5% of the
A. pittii strains were identiﬁed with log scores >2.3, a fact that
might reﬂect the need to include more diverse representative
signatures of A. pittii strains within the Bruker database.
TABLE 1. MALDI-TOF MS identiﬁcation of Acinetobacter spp. relative to log score values
Log score A. baumannii (%) A. pittii (%) A. nosocomialis (%)
Other Acinetobacter
species (%) Total (%)
2.3–3.0 18 (100) 13 (76.5) 18 (100) 3 (42.9) 52 (86.7)
2.0–2.3 0 4 (23.5) 0 3 (42.9) 7 (11.6)
1.7–2.0 0 0 0 1 (14.2) 1 (1.7)
<1.7 0 0 0 0 0
Total 18 17 18 7 60/60
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All reference Acinetobacter spp. included in this study were
correctly identiﬁed with log scores ranging between 2.2 and
2.5, except for strain Acinetobacter gen. sp. 17BJ-209, which
was incorrectly identiﬁed as A. junii with a log score of 1.7.
MALDI-TOF MS analysis of all isolates directly from grown
colonies instead of processed bacterial extracts yielded very
similar results provided that freshly grown cultures (<24 h)
were used and that the amount of colony spotted onto the
agar plates was optimized (data not shown).
To assess the accuracy of species identiﬁcation by MALDI-
TOF MS we compared the above-mentioned results with
those obtained by molecular identiﬁcation methods such as
ARDRA and recA/ITS sequencing. The presence of blaOXA-51
was also analysed because it has been suggested to be highly
speciﬁc for A. baumannii [25]. ARDRA was used as our refer-
ence standard because it is likely to be the most reliable
method for the identiﬁcation of members of the Ab group.
In general, MALDI-TOF MS correlated well with all three
methods. ITS sequencing correctly identiﬁed 98.3% (59/60)
of the strains, which is in good agreement with that reported
by Chang et al. [10], and recA analysis showed an identiﬁca-
tion rate of 100% at the species level.
FIG. 1. Comparison of representative A. bau-
mannii, A. pittii and A. nosocomialis peak proﬁles
(m/z) generated by MALDI-TOF MS. a.u., arbi-
trary intensity given by the software.
FIG. 2. Dendogram derived from the MALDI-
TOF MS-speciﬁc signatures for all Acinetobacter
spp. included within the Bruker database plus
speciﬁc signatures for A. baumannii, A. pittii and
A. nosocomialis created in this study. Distance
values are relative and normalized to a maxi-
mal value of 1000.
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FIG. 3. Dendograms derived from the ITS (a) and recA (b) sequences. GeneBank accession numbers for all reference ITS and recA sequences
are included within the corresponding labelling of each taxon. The scale bar indicates a genetic distance of 0.01 and the numbers shown next to
each node represent the percentage bootstrap value of 1000 replicates.
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PCR ﬁngerprinting of ITS and particularly recA provide an
accurate identiﬁcation of strains belonging to the Ab group,
but both methods are laborious and time-consuming.
Only two discrepancies were found among the four meth-
ods. (i) Strain Acinetobacter gen. sp. 17BJ-209 [26] was identi-
ﬁed as Acinetobacter gen. sp. 17 by ARDRA, ITS and recA
sequencing, but as A. junii by MALDI-TOF (albeit with a log
score of 1.7). The protein signature of Acinetobacter gen. sp.
17, however, is missing in the Bruker database, which would
account for the failure of MALDI-TOF MS to correctly iden-
tify this isolate. It is worth mentioning that ARDRA analysis
of A. junii and Acinetobacter gen. sp. 17 with the initial ﬁve
enzymes generates identical patterns of bands and, therefore,
additional restriction with both BfaI and BsmAI is needed for
accurate identiﬁcation, which indicates the closeness of these
strains and may explain misidentiﬁcation by MALDI-TOF MS.
(ii) Strain A. pittii-91, presumably representing A. pittii, was
identiﬁed as Acinetobacter gen. sp. 14BJ by ARDRA and recA
sequencing but as A. pittii by both MALDI-TOF (with a log
score of 2.0) and ITS sequencing. Of note, the protein signa-
ture for Acinetobacter gen. sp. 14BJ is also missing in the Bru-
ker database. Strain A. pittii-91 was shown to be haemolytic
when grown on blood agar plates, a trait shared among
genomic species 13–17 from Bouvet and Jeanjean (BJ) [27]
but not by A. pittii, thus conﬁrming the reliability of the refer-
ence standard. Isolates belonging to Acinetobacter gen. sp.
13BJ to 15BJ and Acinetobacter gen. sp. 16 are rarely found in
clinical samples, providing a very limited number of available
reference strains and, therefore, these groups are poorly
deﬁned with methodologies other than DNA-DNA hybrid-
ization [8].
The recA and ITS sequences from all isolates as well as
from a few reference strains retrieved from GeneBank were
used to construct representative dendograms in order to
analyse their correct clustering (Fig. 3). recA and ITS-gener-
ated dendograms provided four deﬁned clusters, one for
each genomic species included within the Acb complex.
A. calcoaceticus and A. pittii were also grouped in a larger
monophyletic group, suggesting a close genetic relatedness,
while A. baumannii and A. nosocomialis are apparently more
closely related to each other than to the other members of
the Acb complex, in agreement with the clustering of geno-
mic species by MALDI-TOF MS-speciﬁc signatures and DNA-
DNA hybridization [28].
PCR detection of the blaOXA-51 gene only generated posi-
tive ampliﬁcation in those strains correctly identiﬁed as
A. baumannii, thus reinforcing the screening value of this
method to rapidly differentiate A. baumannii from other
Acinetobacter spp. [25] despite a few exceptions described
in the literature [29].
The correct identiﬁcation of the different species within
the Ab group is of great interest because infections caused by
these organisms have a different impact on clinical outcome
and, hence, different treatment and management approaches
are needed [14]. Adjustment of the default MALDI-TOF MS
database allowed the identiﬁcation of all members of the Ab
group as well as other Acinetobacter spp. with similar accuracy
compared with ARDRA, recA and ITS sequencing and high-
lighted the strong dependency of MALDI-TOF MS, ITS and
recA sequencing on a validated reference database that dra-
matically inﬂuences the accuracy of identiﬁcation.
When compared with conventional methods in the diag-
nostic routine laboratories for Acinetobacter spp., MALDI-
TOF MS becomes a robust method capable of identifying
over 98% of all isolates to the species level in <5 min per
sample, at a lower overall cost and with similar or better
accuracy. Further database reﬁnements will improve the
rapid identiﬁcation of additional species and might even allow
the characterization of resistance and virulence determinants
when speciﬁc protein peaks are produced [30], making
MALDI-TOF MS the ideal technique for routine clinical
microbiology testing.
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